Evidence map›Paper›PMID 41253707›Full record

ArticleJournal of applied clinical medical physics2025

NTCP model guided whole brain radiation re-planning to reduce risk of acute xerostomia and dry eye.

Gregory Szalkowski, Jeffrey Fenoli, Mary Oakey, Xianming Tan, Kevin A Pearlstein, Trevor J Royce, Bhishamjit S Chera, Shiva K Das, Kyle Wang, Panayiotis Mavroidis

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gregory SzalkowskiDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Jeffrey FenoliDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Mary OakeyDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Xianming TanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kevin A PearlsteinDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Trevor J RoyceDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Bhishamjit S CheraDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Shiva K DasDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Kyle WangDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
Panayiotis MavroidisDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-9066-5123

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrevious work has shown that whole brain radiation (WBRT) can lead to acute xerostomia and dry eye from dose delivered to the parotid and lacrimal glands, respectively. We performed a retrospective study to assess whether a previously developed normal tissue complication probability (NTCP) model could guide planning to reduce the risk of these complications. We also evaluate if the use of VMAT/IMRT instead of 3D planning can reduce the risk of side effects while maintaining dose to the brain.

methodsWe identified 11 patients who had previously received WBRT to 30 Gy in 10 fractions using 3D-conformal radiation therapy without prospective delineation of the parotid or lacrimal glands. For each patient, these structures were contoured and new 3D and IMRT plans were created to limit the V

resultsThe 3D re-plans significantly (p < 0.001) reduced the estimated risk of xerostomia, by 12.2 ± 4.5%, but did not significantly (p > 0.025) reduce the risk of dry eye. The IMRT re-plans significantly (p < 0.001) reduced the risk of xerostomia, by 20.6 ± 7.2%, and dry eye by 11.0 ± 3.8%. Both re-plans maintained target coverage.

conclusionBy using parameter values obtained from NTCP models, we were able to create whole brain plans that lowered the estimated risk of xerostomia and dry eye while maintaining target coverage.

Indexed as

Brain NeoplasmsDry Eye SyndromesRadiation InjuriesRadiotherapy, ConformalXerostomiaHumansOrgans at RiskRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRetrospective Studiesdry eyeLKBNTCPradiobiological parametersrelative serialitywhole brain radiation therapyxerostomia

Identifiers

PMID41253707
PMCPMC12626740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.